ACLU Defends Standing Of Lone Gene Patent Plaintiff

Law360, New York (June 11, 2012, 8:56 PM EDT) -- The sole remaining plaintiff in a suit challenging the validity of Myriad Genetics Inc.'s breast cancer gene patents did not lose his standing to sue when he changed jobs, the American Civil Liberties Union told the Federal Circuit on Thursday, fighting Myriad's request to toss the case.

When it ruled last year that the genes isolated by Myriad are patentable, the Federal Circuit held that only one of the 20 named plaintiffs represented by the ACLU, Dr. Harry Ostrer, had standing to challenge the validity of...
To view the full article, register now.